US Stock MarketDetailed Quotes

RARE Ultragenyx Pharmaceutical

Watchlist
  • 42.070
  • -1.580-3.62%
Close Jan 10 16:00 ET
  • 42.070
  • 0.0000.00%
Post 20:01 ET
3.88BMarket Cap-6.63P/E (TTM)

Ultragenyx Pharmaceutical Key Stats

Ultragenyx Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 147.219M--
--2024/Q4-- / 143.940M--
Nov 5, 20242024/Q3139.494M / 135.247M--
Aug 1, 20242024/Q2147.026M / 123.214M--
May 2, 20242024/Q1108.833M / 116.438M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 147.219M--
--2024/Q4-- / 143.940M--
Nov 5, 20242024/Q3139.494M / 135.247M--
Aug 1, 20242024/Q2147.026M / 123.214M--
May 2, 20242024/Q1108.833M / 116.438M--

Unlock Free Earnings Estimates

Ultragenyx Pharmaceutical Earnings Reports

Read more

Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Analysis

Analyst Rating

Updated: Jan 10, 2025

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data